Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-15.98 Insider Own0.28% Shs Outstand329.83M Perf Week-1.66%
Market Cap65.55B Forward P/E10.99 EPS next Y18.09 Insider Trans0.00% Shs Float327.35M Perf Month3.20%
Income-5271.00M PEG- EPS next Q4.01 Inst Own93.00% Short Float4.18% Perf Quarter7.72%
Sales16.09B P/S4.07 EPS this Y24.90% Inst Trans1.17% Short Ratio5.79 Perf Half Y24.91%
Book/sh178.28 P/B1.11 EPS next Y4.09% ROA-8.70% Target Price195.00 Perf Year41.62%
Cash/sh13.81 P/C14.39 EPS next 5Y3.15% ROE-13.90% 52W Range114.27 - 202.21 Perf YTD3.96%
Dividend2.96 P/FCF15.20 EPS past 5Y-36.00% ROI-4.80% 52W High-1.16% Beta1.69
Dividend %1.49% Quick Ratio0.90 Sales past 5Y43.40% Gross Margin84.60% 52W Low74.91% ATR1.94
Employees16900 Current Ratio1.00 Sales Q/Q3.60% Oper. Margin-53.20% RSI (14)65.68 Volatility0.88% 0.91%
OptionableYes Debt/Eq0.39 EPS Q/Q- Profit Margin-52.90% Rel Volume0.72 Prev Close198.74
ShortableYes LT Debt/Eq0.32 EarningsFeb 10 BMO Payout- Avg Volume2.36M Price199.87
Recom2.80 SMA203.12% SMA504.11% SMA20018.85% Volume1,106,275 Change0.57%
Jan-22-20Downgrade Wells Fargo Overweight → Equal Weight $198
Nov-19-19Downgrade UBS Buy → Neutral $189 → $203
Aug-07-19Downgrade Guggenheim Buy → Neutral
Jul-18-19Downgrade SVB Leerink Outperform → Mkt Perform
Jul-16-19Downgrade Bernstein Outperform → Mkt Perform
Jun-11-19Initiated Barclays Underweight $133
May-28-19Initiated Goldman Neutral
Apr-15-19Initiated Jefferies Hold
Mar-20-19Initiated SunTrust Buy $178
Jan-31-19Downgrade Credit Suisse Outperform → Neutral
Jan-30-19Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-30-19Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-09-18Resumed Guggenheim Buy
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Feb-21-20 10:15AM  Form 8.3 - Allergan plc Business Wire
09:58AM  Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS Zacks
05:34AM  Form 8.3 - Allergan plc Business Wire
Feb-20-20 04:51PM  4 Most Popular Healthcare Stocks Among Hedge Funds: Q4 Rankings Insider Monkey
12:37PM  David Abrams Buys 2 Stocks in 4th Quarter GuruFocus.com
10:23AM  One of Your Stock Investments is Being Acquired: Now What? Zacks
10:15AM  Form 8.3 - Allergan plc Business Wire
09:54AM  Form 8.3 - ALLERGAN PLC - Amendment Business Wire
06:05AM  Form 8.3 - Allergan plc Business Wire
Feb-19-20 12:59PM  Beth Fegan of FeganScott Law Firm Named Co-Lead Counsel in Allergan BIOCELL Class Action Business Wire
09:17AM  Form 8.3 - ALLERGAN PLC - AMENDMENT Business Wire
07:10AM  FORM 8.3 - ALLERGAN PLC Business Wire
Feb-18-20 02:56PM  Consumer groups, unions oppose fix for planned merger of AbbVie and Allergan Reuters
10:00AM  AbbVie's $63 Billion Allergan Takeover Is Looming Is It Time To Add Shares? Investor's Business Daily
Feb-17-20 10:15AM  Form 8.3 - Allergan plc Business Wire
08:35AM  Form 8.3 - ALLERGAN PLC - Amendment Business Wire
06:59AM  FORM 8.3 - ALLERGAN PLC Business Wire
05:01AM  Form 8.3 - ALLERGAN PLC - AMENDMENT Business Wire
Feb-14-20 04:15PM  Announcement under the Irish Takeover Rules: Relevant Securities in Issue - February 14, 2020 PR Newswire
10:37AM  Form 8.3 - Allergan plc Business Wire
09:52AM  Pharma Stock Roundup: ABBV, AGN Post Q4 Results, Another Alzheimer's Study Fails Zacks
09:50AM  Ironwood (IRWD) Surpasses Q4 Earnings and Sales Estimates Zacks
07:10AM  Positive Earnings Look as If Theyre Already Priced in to Teva Stock InvestorPlace
07:00AM  Announcement under Rule 8.1(a) of the Irish Takeover Rules: Dealings by Offerors, Offerees or Parties Acting in Concert With Them for Themselves or for Discretionary Clients PR Newswire
06:17AM  FORM 8.3 - ALLERGAN PLC Business Wire
Feb-13-20 10:15AM  Form 8.3 - Allergan plc Business Wire
07:09AM  Form 8.3 - ALLERGAN PLC Business Wire
Feb-12-20 05:33PM  Top Stock Analyst Reports for Merck, Philip Morris & American Tower Zacks
07:21AM  FORM 8.3 - ALLERGAN PLC Business Wire
05:16AM  Form 8.3 - ALLERGAN PLC - Amendment Business Wire
Feb-11-20 03:59PM  INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Allergan plc and Encourages Investors with Losses to Contact the Firm Business Wire
10:38AM  Company News for Feb 11, 2020 Zacks
10:35AM  Form 8.3 - Allergan plc Business Wire
07:33AM  Form 8.3 - ALLERGAN PLC Business Wire
07:23AM  The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology Benzinga
04:50AM  Form 8.3 - Allergan plc- Amendment Business Wire
Feb-10-20 04:43PM  S&P 500, Nasdaq close at records as investors look past coronavirus to solid corporate earnings MarketWatch
04:18PM  Allergan Rides Botox Sales To Top Forecasts As AbbVie Merger Looms Investor's Business Daily
03:11PM  Allergan (AGN) Surpasses Q4 Earnings and Sales Estimates Zacks
12:00PM  Form 8.3 - Allergan plc Business Wire
10:13AM  What's in Store for Ironwood (IRWD) This Earnings Season? Zacks
09:36AM  Stocks open slightly lower as investors gauge coronavirus impact MarketWatch
09:31AM  Allergan Tops Q4 Earnings Forecast, Sees $63 Billion AbbVie Deal Closing in Q1 TheStreet.com
09:00AM  Allergan Reports Q4 Earnings Beat Benzinga
07:44AM  Benzinga Pro's Top 5 Stocks To Watch For Mon., Feb. 10, 2020: NIO, SPG, AGN, LB, UA Benzinga
07:23AM  Top 5 Things to Know in the Market on Monday, 10th February Investing.com
07:14AM  Allergan's stock rises as adjusted profit, revenue beat expectations MarketWatch
06:52AM  Form 8.3 - ALLERGAN PLC Business Wire
05:01AM  7 Stocks Join the Dividend Aristocrats, and Two More Numbers to Know Barrons.com
04:07AM  Stocks - Taubman Soars in Premarket on Simon Bid; Xerox Raises HP Offer Investing.com
02:02AM  Stocks - Futures Point to Small Gains; Virus Breeds Uncertainty Investing.com
Feb-07-20 02:07PM  AbbVie's (ABBV) Q4 Earnings Beat, 2020 View Solid, Stock Up Zacks
10:17AM  Form 8.3 - Allergan plc Business Wire
09:33AM  AbbVie Jumps on Strong Earnings. Thats Not the Only Reason. Barrons.com
09:00AM  Form 8.3 - Allergan PLC Business Wire
08:10AM  AbbVie's stock rises on strong earnings MarketWatch
07:44AM  AbbVie leans on new treatments to forecast upbeat 2020 profit Reuters
05:44AM  Form 8.3 - ALLERGAN PLC Business Wire
Feb-06-20 11:35AM  Form 8.3 - ALLERGAN PLC - Amendment Business Wire
10:51AM  Allergan (AGN) to Report Q4 Earnings: What's in the Cards? Zacks
10:15AM  Form 8.3 - Allergan plc Business Wire
06:56AM  FORM 8.3 - ALLERGAN PLC Business Wire
03:42AM  Form 8.3 - ALLERGAN PLC - AMENDMENT Business Wire
Feb-05-20 04:11PM  13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market Benzinga
02:25PM  David Carlson Trims Allergan, Charles Schwab Positions GuruFocus.com
10:37AM  Can Humira/Cancer Drugs Help AbbVie (ABBV) Beat Q4 Earnings? Zacks
10:22AM  Form 8.3 - Allergan plc Business Wire
09:27AM  Form 8.3 - ALLERGAN PLC - Amendment Business Wire
06:55AM  Form 8.3 - Allergan plc Business Wire
04:46AM  FORM 8.3 - ALLERGAN PLC AMENDMENT Business Wire
Feb-04-20 10:21AM  Form 8.3 - Allergan plc Business Wire
09:42AM  FORM 8.3 - ALLERGAN PLC - AMENDMENT Business Wire
08:03AM  AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards? Zacks
07:17AM  Form 8.3 - ALLERGAN PLC Business Wire
Feb-03-20 05:36PM  4th-Quarter Update: David Carlson's Elfun Trusts GuruFocus.com
01:00PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Allergan plc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:10AM  VVUS: ZenPep Deal Demonstrates PERT Interest Zacks Small Cap Research
10:10AM  FORM 8.3 - ALLERGAN PLC Business Wire
07:30AM  BOTOX® Cosmetic (onabotulinumtoxinA) Launches Be The Difference Philanthropic Program PR Newswire
Jan-31-20 03:11PM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Allergan plc and Encourages Investors with Losses to Contact the Firm Business Wire
10:32AM  Pharma Stock Roundup: LLY, PFE Q4 Results, JNJ's Coronavirus Vaccine Initiative Zacks
10:25AM  Form 8.3 - Allergan plc Business Wire
09:53AM  Form 8.3 - Allergan plc Business Wire
07:30AM  Allergan to Report Fourth Quarter and Full Year 2019 Financial Results PR Newswire
Jan-30-20 10:22AM  Form 8.3 - Allergan plc Business Wire
10:04AM  Form 8.3 - Allergan plc - Amendment Business Wire
09:43AM  FORM 8.3 - ALLERGAN PLC Business Wire
Jan-29-20 09:54AM  Alkermes' (ALKS) NDA for ALKS 3831 Accepted by FDA for Review Zacks
08:14AM  Form 8.3 - ALLERGAN PLC Business Wire
Jan-28-20 02:36PM  Merck's Dificid Gets FDA Approval in Pediatric Indication Zacks
12:31PM  Allergan (AGN) Earnings Expected to Grow: Should You Buy? Zacks
11:22AM  Form 8.3 - Allergan plc - Amendment Business Wire
10:52AM  Allergan to Divest Brazikumab, Zenpep to Close AbbVie Merger Zacks
10:25AM  Form 8.3 - Allergan plc Business Wire
08:04AM  Form 8.3 - ALLERGAN PLC Business Wire
Jan-27-20 04:29PM  Dow ends more than 450 points lower as spread of coronavirus quashes buying sentiment MarketWatch
04:17PM  The Key Move AbbVie Just Made To Help It Clinch A $63 Billion Deal Investor's Business Daily
02:01PM  Jim Cramer: 6 Stocks to Buy on Coronavirus Fears TheStreet.com
12:03PM  Form 8.3 - Allergan plc - Amendment Business Wire
09:41AM  Allergan to divest two drugs, to move forward with AbbVie deal MarketWatch
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women's health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. In addition, it develops medical and cosmetic treatments; therapies for non-alcoholic steatohepatitis and other liver diseases; inhibitor for the treatment of psoriasis and other autoimmune disorders; atopic dermatitis drug candidate; peri-ocular rings for extended drug delivery and reducing elevated intraocular pressure in glaucoma patients; and treatments for neurodegenerative disorders, including Alzheimer's disease. Further, the company develops RST-001, a novel gene therapy for the treatment of retinitis pigmentosa; small molecule therapeutics for inflammatory and fibrotic diseases; topical medicines for fat reduction; and delivery system and botulinum toxin-based prescription products. It has a collaboration, option, and license agreement with Lyndra, Inc.; strategic alliance and option agreement with Editas Medicine, Inc.; and gene therapy research collaboration with The National Institute for Bioprocessing Research and Training. Allergan plc also has licensing agreements with Assembly Biosciences, Inc.; MedImmune; and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LChairman, President and CEOMar 07Buy143.671,760252,858170,666Mar 07 03:19 PM